Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta. 13 August 2019
Americas
Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion. 9 August 2019
Big Pharma
The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced. 8 August 2019
Americas
The US Federal Trade Commission is requiring medical device maker Boston Scientific to divest business, as part of a settlement resolving antitrust charges related to its acquisition of UK-based healthcare company BTG. 8 August 2019
Biotechnology
In future, the more efficient targeting of treatments to specific patient populations that will actually benefit from them, could offset the price of more expensive but well targeted and effective treatments that will be suitable for increasingly smaller patient populations. Daniel Lim and Anna Jackson of Kirkland & Ellis explain. 8 August 2019
Big Pharma
A subsidiary of Akebia Therapeutics has entered into a settlement agreement with Endo-owned Par Pharmaceutical. 7 August 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria. 7 August 2019
article
Hooper, Lundy and Bookman has appointed Andrew Woodmansee to head up a new IP practice at the firm. 7 August 2019
Big Pharma
A subsidiary of Irish pharmaceutical company Allergan is to pay a combined total of $2.7 million to three organisations that were part of an antitrust class against the drugmaker. 6 August 2019
Big Pharma
The European Union has asked the World Trade Organization to establish a panel on Turkey’s measures on pharmaceutical products. 5 August 2019